KANE_&_ROSS_CLINICS_LIMIT - Accounts


Company Registration No. 04837185 (England and Wales)
KANE & ROSS CLINICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020
PAGES FOR FILING WITH REGISTRAR
KANE & ROSS CLINICS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
KANE & ROSS CLINICS LIMITED
BALANCE SHEET
AS AT
31 JULY 2020
31 July 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Tangible assets
3
69,405
58,357
Investment properties
4
800,000
800,000
869,405
858,357
Current assets
Stocks
1,900
2,300
Debtors
5
13,060
44,197
Cash at bank and in hand
36,378
58,011
51,338
104,508
Creditors: amounts falling due within one year
6
(158,181)
(144,670)
Net current liabilities
(106,843)
(40,162)
Total assets less current liabilities
762,562
818,195
Provisions for liabilities
(24,721)
(21,991)
Net assets
737,841
796,204
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
737,741
796,104
Total equity
737,841
796,204

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 July 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

KANE & ROSS CLINICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JULY 2020
31 July 2020
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 21 April 2021 and are signed on its behalf by:
Mr M Kane
Director
Company Registration No. 04837185
KANE & ROSS CLINICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2020
- 3 -
1
Accounting policies
Company information

Kane & Ross Clinics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Wessex House, Teign Road, Newton Abbot, Devon, TQ12 4AA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for professional services provided in the normal course of business and is recognised when the work is performed.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Leasehold
Straight line over the lease term
Fixtures, fittings & equipment
25% Straight line basis
Motor vehicles

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Investment properties

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

KANE & ROSS CLINICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2020
1
Accounting policies
(Continued)
- 4 -
1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

1.8
Provisions

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

KANE & ROSS CLINICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2020
1
Accounting policies
(Continued)
- 5 -
1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
4
4
KANE & ROSS CLINICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2020
- 6 -
3
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
Cost
At 1 August 2019
171,127
140,231
311,358
Additions
-
0
33,003
33,003
Disposals
-
0
(400)
(400)
At 31 July 2020
171,127
172,834
343,961
Depreciation and impairment
At 1 August 2019
147,941
105,060
253,001
Depreciation charged in the year
1,546
20,109
21,655
Eliminated in respect of disposals
-
0
(100)
(100)
At 31 July 2020
149,487
125,069
274,556
Carrying amount
At 31 July 2020
21,640
47,765
69,405
At 31 July 2019
23,186
35,171
58,357
4
Investment property
2020
Fair value
At 1 August 2019 and 31 July 2020
800,000

Investment property comprises a third ownership of a residential property. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.

5
Debtors
2020
2019
Amounts falling due within one year:
Trade debtors
7,810
3,280
Other debtors
5,250
40,917
13,060
44,197
KANE & ROSS CLINICS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2020
- 7 -
6
Creditors: amounts falling due within one year
2020
2019
Trade creditors
1,345
2,223
Corporation tax
89,086
113,256
Other taxation and social security
1,280
(1,110)
Other creditors
66,470
30,301
158,181
144,670
7
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2020
2019
Within one year
214,000
214,000
Between two and five years
856,000
856,000
In over five years
2,496,667
2,710,667
3,566,667
3,780,667

The lease liability relates to property lease commitments with the main lease being £214,000 pa for 16 years and 8 months.

9
Events after the reporting date

These statutory accounts are being approved during the second wave of the global Covid-19 pandemic. Since the first lockdown in March 2020 the directors have re-engineered the business such that turnover has started to approach historical levels. These are uncertain times but the directors are confident that the company can trade through these current challenges.

2020-07-312019-08-01false21 April 2021CCH SoftwareCCH Accounts Production 2021.100No description of principal activityMr M KaneMs S RossMr M Kane048371852019-08-012020-07-31048371852020-07-31048371852019-07-3104837185core:LandBuildings2020-07-3104837185core:OtherPropertyPlantEquipment2020-07-3104837185core:LandBuildings2019-07-3104837185core:OtherPropertyPlantEquipment2019-07-3104837185core:CurrentFinancialInstrumentscore:WithinOneYear2020-07-3104837185core:CurrentFinancialInstrumentscore:WithinOneYear2019-07-3104837185core:CurrentFinancialInstruments2020-07-3104837185core:CurrentFinancialInstruments2019-07-3104837185core:ShareCapital2020-07-3104837185core:ShareCapital2019-07-3104837185core:RetainedEarningsAccumulatedLosses2020-07-3104837185core:RetainedEarningsAccumulatedLosses2019-07-3104837185bus:CompanySecretaryDirector12019-08-012020-07-3104837185core:LandBuildingscore:LeasedAssetsHeldAsLessee2019-08-012020-07-3104837185core:FurnitureFittings2019-08-012020-07-31048371852018-08-012019-07-3104837185core:LandBuildings2019-07-3104837185core:OtherPropertyPlantEquipment2019-07-31048371852019-07-3104837185core:LandBuildings2019-08-012020-07-3104837185core:OtherPropertyPlantEquipment2019-08-012020-07-3104837185core:WithinOneYear2020-07-3104837185core:WithinOneYear2019-07-3104837185core:BetweenTwoFiveYears2020-07-3104837185core:BetweenTwoFiveYears2019-07-3104837185core:MoreThanFiveYears2020-07-3104837185core:MoreThanFiveYears2019-07-3104837185bus:PrivateLimitedCompanyLtd2019-08-012020-07-3104837185bus:SmallCompaniesRegimeForAccounts2019-08-012020-07-3104837185bus:FRS1022019-08-012020-07-3104837185bus:AuditExemptWithAccountantsReport2019-08-012020-07-3104837185bus:Director12019-08-012020-07-3104837185bus:Director22019-08-012020-07-3104837185bus:CompanySecretary12019-08-012020-07-3104837185bus:FullAccounts2019-08-012020-07-31xbrli:purexbrli:sharesiso4217:GBP